Deep Track Capital
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio1 active
4Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Imbria Pharmaceuticals
20Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Imbria Pharmaceuticals | Biotech | Active | Dec 16, 2025 | $140.2M |
| MBX Biosciences | Biotech | Public | Nov 18, 2022 | $95.5M |
| Attovia Therapeutics | Biotech | Public | — | — |
| Hemab Therapeutics | Biotech | Public | — | — |
| Tubulis | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#49
Raises, 12 months#22
Co-investors#105
Co-investors
- Frazier Healthcare PartnersVenture capital2 shared
- RA CapitalVenture capital2 shared
- Access BiotechnologyVenture capital1 shared
- Andera PartnersVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Catalio Capital ManagementVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- EQT Life SciencesVenture capital1 shared
- Goldman Sachs AlternativesVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.